GEM Premier 7000 wins four prestigious awards

We are very proud to announce that our new GEM Premier 7000 with iQM3—the first-ever, rapid point-of-care blood gas testing system with integrated hemolysis detection—has been honored with four major awards, recognizing its significant contributions to medical technology.

Three of the four were 2024 Excellence Awards, were presented by the Medical Device Network, and include:

  • Innovation Award, recognizing the system as the first to integrate hemolysis detection for improved diagnostic accuracy.
  • Research & Development Award, honoring the system’s advanced features, from its all-in-one GEM PAK cartridge and continuous quality management.
  • Product Launch Award, celebrating its successful market introduction in the United State, enhancing efficiency and patient care in acute settings.

The Excellence Awards celebrate the greatest achievements and innovations in the medical device industry. The Medical Devices Network is a social business platform that brings together medical professionals, buyers, manufacturers, distributors, and vendors for the purpose of collaboration and procurement of medical products, services, and solutions.

The fourth award was the 2024 R&D 100 Award, which recognizes the top 100 new commercial products, technologies and materials from across the globe for their technological significance, awarded by R&D World.This award recognized the system’s impact on improving healthcare operations and patient outcomes.

While it’s clear that the GEM Premier 7000 with iQM3 system is a breakthrough in blood gas testing, these awards reinforce this and help distinguish our innovation as the best in the market, and our passion for patient care, unstoppable!

Congratulations to the GEM Premier 7000 product team for its dedication to innovation and excellence in healthcare technology.

EEMEA Team

Last modified on Tuesday, 24 February 2026 11:50

 

All rights reserved. © werfen.com

Get in touch

with the EEMEA team:

eemea@werfen.com

 

werfenplain

Issues

Go to top